Profil
David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
He is an Independent Director at Abliva AB since 2017.
He is also a Director at Amylonix AB and Disruptive Pharma Holding AB. Formerly, Mr. Bejker was Chief Executive Officer & Director at Affibody AB from 2003 to 2005.
Other former roles include Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduate studies at Stockholm School of Economics.
Aktiva positioner av David Bejker
| Företag | Position | Start |
|---|---|---|
| ABLIVA AB | Direktör/Styrelseledamot | 2017-04-27 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Verkställande Direktör | 2018-12-01 |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Direktör/Styrelseledamot | - |
Disruptive Pharma Holding AB | Direktör/Styrelseledamot | - |
Tidigare kända positioner av David Bejker
| Företag | Position | Slut |
|---|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Verkställande Direktör | 2005-07-01 |
| LIDDS AB | Direktör/Styrelseledamot | - |
| NEXSTIM PLC | Företagsledare/Principal | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Företagsledare/Principal | - |
David Bejkers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexstim Oyj
Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Health Technology |
Disruptive Pharma Holding AB |
















